ASCOT Legacy: Long-term Survival Benefit of BP, Lipid Lowering
[Speaker] Young Joon Hong/Chonnam National Univ., Korea
Choice of Antithrombotic Therapy in NVAF and Concomitant Coronary Artery Disease
[Speaker] Ziad Hijazi/Uppsala Univ., Sweden